AllianceBernstein Holding Azioni (NYSE: AB)

Ultime notizie per AllianceBernstein Holding (NYSE:AB) Azioni

AllianceBernstein Holding

AllianceBernstein provides investment management services to institutional (42% of assets under management), retail (41%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of October 2024, AB had $793 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (42%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.

Dividend Yield

News

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

CSWC

Gli esperti segnalano 3 titoli che offrono rendimenti superiori alla media, ideali per gli investitori in cerca di reddito passivo.

3 azioni finanziarie con rendimenti da dividendo fino all&#39;11%

Rolling,Meadows,,Illinois,,Usa,-,March,27,,2022:,Gallaghers,Sign

Media

AMAT

FUBO

L&#39;analista della CNBC indica le società su cui puntare. I consigli per un portafoglio di investimenti solido.

Jim Cramer svela le sue scelte vincenti: ecco i titoli da non perdere

AllianceBernstein Holding LP

ABRDN ASIA-PAC INCOME FD by ABRDN ASIA-PAC INCOME FD

abrdn Asia-Pacific Income Fund VCC

AUTOMATIC BANK SERVICES by Automatic Bank Services Ltd.

Automated Bank Services Ltd

ALBA SE by ALBA SE

American Battery Technology Company - Common Stock

American Battery Technology Co

A2B AUSTRALIA LTD by A2B Australia Ltd.

ABRDN ASIAN INCOME FUND by abrdn Asian Income Fund Limited

AUBURN BANCORP INC by Auburn Bancorp, Inc.

Auburn Bancorp Inc

ABBC Coin

ABB Ltd

Abrasilver Resource Corp

ABRASILVER RESOURCE CORP by AbraSilver Resource Corp

AbbVie Inc

Abby Inc

Athabasca Minerals Inc

Ameris Bancorp

ABC arbitrage SA

ABCO Energy Inc

ABACUS MINING & EXPL ORD by Abacus Mining & Exploration Corp.

Abacus Mining & Exploration Corp

Abacus Group

AbCellera Biologics Inc

ABCAM PLC SPONSORED ADS

Ambase Corp

Alpha Blue Capital US Small-Mid Cap Dynamic ETF

ABCAM PLC ORD by Abcam PLC

Alm Brand AS

AB Dynamics PLC

AMBASSADOR FOOD SVCS CORP by Ambassador Food Services Corp.

ABINGDON HEALTH LTD by Abingdon Health Ltd.

Abingdon Health PLC

Abeona Therapeutics Inc

VISION LITHIUM INC by Vision Lithium Inc.

Vision Lithium Inc

Absolute Select Value ETF

Ambev S.A. American Depositary Shares (Each representing 1 Common Share)

Ambev SA

Abacus FCF Leaders ETF

ABERTIS INFRAESTRCTS ORD by Abertis Infraestructuras SA

ABERFORTH SM CO PLC by Aberforth Smaller Companies Trust PLC

Asbury Automotive Group Inc

Abengoa SA

ABG SUNDAL COLLIER ASA by ABG Sundal Collier ASA

ABG Sundal Collier Holding ASA

ALFEN BEHEER B V ADR by Alfen Beheer B.V.

Alfen NV

Abacus Tactical High Yield ETF

Argent Large Cap ETF

Ability Inc

ATHENA BITCOIN GLOBAL by ATHENA BITCOIN GLOBAL

Athena Bitcoin Global

AMER BASKETBALL ASSN INC by American Basketball Association, Inc.

Abacus Global Management, Inc. - Class A Common Stock

Abacus Global Management Inc

ABALANCE CORP by Abalance Corp.

Abacus FCF Real Assets Leaders ETF

ABLE ENERGY INC by Able Energy, Inc.

Abacus FCF International Leaders ETF

ALTEN BOULOGNE-BILLANCORT by Alten Boulogne-Billancourt

Alten

Abacus Global Management, Inc. - 9.875% Fixed Rate Senior Notes due 2028

Abacus FCF ETF Trust Abacus FCF Small Cap Leaders ETF

AMERICAN BILTRITE INC by American Biltrite, Inc.

American Biltrite Inc

Able View Global Inc. - Class B Ordinary Shares

Able View Global Inc

ABM Industries Inc

ALBIOMA by Albioma

ABCOURT MINES INC B by Abcourt Mines Inc.

Abcourt Mines Inc

AMER BIO MEDICA CORP by American Bio Medica Corp.

American Bio Medica Corp

Prodigy Gold NL

ABN AMRO Bank NV

ADVANCED BIOMEDICAL TECHS by Advanced BioMedical Technologies, Inc.

Advanced BioMedical Technologies Inc

Aben Minerals Ltd

Airbnb Inc

Tidal Trust II YieldMax ABNB Option Income Strategy ETF

ABOITIZ EQUITY VNTRS INC by Aboitiz Equity Ventures, Inc.

Aboitiz Equity Ventures Inc

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals Inc

Abacus FCF Innovation Leaders ETF

Abpro Holdings Inc

AIRBORNE SEC & PROT SVCS by Airborne Security & Protective Services, Inc.

Airborne Security & Protection Services Inc

AB INTL GROUP CORP NEW by AB INTL Group Corp.

AB International Group Corp

Arbor Realty Trust Inc

Arbor Metals Corp

Arbor Realty Trust 6.375% Series D Cumulative Redeemable Preferred Stock, Liquidation Preference $25.00 per Share

Arbor Realty Trust 6.25% Series E Cumulative Redeemable Preferred Stock

Arbor Realty Trust 6.25% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, Liquidation Preference $25.00 per share

AB SCIENCE PARIS ORD by AB Science, Paris

AB Science

Absci Corp

ABACUS STORAGE KING by ABACUS STORAGE KING

ABS-CBN Holdings Corp Shs Philippine Depository Receipts Repr. 1 sh

ABS-CBN Holdings Corp

AIRBOSS OF AMERICA CORP by AirBoss of America Corp.

AirBoss of America Corp

Abbott Laboratories

Arcblock - United States Dollar

ALTEROLA BIOTECH INC by Alterola Biotech, Inc.

Alterola Biotech Inc

AB&T Financial Corp Com

Abits Group Inc

ABOITIZ EQTY VNT UNSP/ADR by Aboitiz Equity Ventures, Inc.

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma Corp

ABVC BioPharma Inc

Above Food Ingredients Inc. - Common Stock

Above Food Ingredients Inc

AFFINITY BEVERAGE GROUP by Affinity Beverage Group, Inc.

Affinity Beverage Group Inc

Barclays analyst Benjamin Budish maintains AllianceBernstein Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>) with a Equal-Weight and raises the price target from $36 to $37.

Barclays Maintains Equal-Weight on AllianceBernstein Holding, Raises Price Target to $37

AllianceBernstein Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>) reported quarterly earnings of $0.80 per share which beat the analyst consensus estimate of $0.78 by 2.56 percent. This is a 9.59 percent increase over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $1.08 billion which beat the analyst consensus estimate of $852.93 million by 26.62 percent. This is a 2.17 percent decrease over sales of $1.10 billion the same period last year.

Earnings

Earnings Beats

AllianceBernstein Holding Q1 Adj. EPS $0.80 Beats $0.78 Estimate, Sales $1.08B Beat $852.93M Estimate

ADXN

ALEX

ALLE

AMAL

AMBP

APOG

APPF

BAFN

BCPC

BELFA

BELFB

BFST

BHLB

BWMX

CBRE

CIVB

CMCSA

CNOB

COUR

CUBI

CURB

DAIO

DGICA

DGICB

ERIE

FARO

FBIZ

FCFS

FCNCA

FFBC

FRME

GBCI

GILD

GLPI

GNFT

GOOG

GOOGL

HELE

HFWA

IBCP

INDV

INTC

ITGR

KNSL

KRNY

LADR

LYTS

MBLY

MGRC

MMSI

MOFG

Earnings Scheduled For April 24, 2025

Barclays analyst Benjamin Budish maintains AllianceBernstein Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>) with a Equal-Weight and raises the price target from $34 to $36.

Comments

AllianceBernstein Holding

Notizie

Ultime notizie per AllianceBernstein Holding (NYSE:AB) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO